Influence of malignant cell clonogenic capacities and position along the maturation pathway on their susceptibility to lymphokine-activated killer cell cytotoxicity

Leukemia and Lymphoma

Volumn 28, Issue 3-4, 1998, Pages 343-353

  Thomas, Xavier ^a,b   Anglaret, Bruno ^a,b   Adeleine, Patrice ^c   Maritaz, Odette ^b   Bailly, Mireille ^b   Fibre, Denis ^a   Archimbaud, Eric ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b CENTRE LÉON BÉRARD   (France)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

Adhesion molecules; Cell differentiation; Clonogenic growth; Interleukin 2; Lymphokine activated killer cells; MHC nonrestricted cytotoxicity

Indexed keywords

CELL ADHESION MOLECULE; CHROMIUM 51; DIMETHYL SULFOXIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; STEM CELL FACTOR;

ARTICLE; CANCER CELL CULTURE; CELL MATURATION; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CELL STRAIN HL 60; CLONOGENESIS; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031904994     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809092689     Document Type: Article

References (35)

1. Rayner, A. A., Grimm, E. A., Lotze, M. T., Wilson, D. J. and Rosenberg, S. A. (1985). Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors. J Natl Cancer Inst, 75, 67-75.
2. Itoh, K., Tilden, A. B. and Balch, C. M. (1986). Lysis of human solid tumor cells by lymphokine-activated natural killer cells. J Immunol, 136, 3910-3915.
3. Dawson, M. M., Johnston, D., Taylor, G. M. and Moore, M. (1986). Lymphokine activated killing of fresh human leukemias. Leuk Res, 10, 683-686.
4. Fierro, M. T., Liao, X., Lusso, P., Bonferroni, M., Marera, L., Cesano, A., Lista, P., Arione, R., Forni, G. and Foa, R. (1988). In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity. Leukemia, 2, 50-54.
5. Trentin, L., Pizzolo, G., Feruglio, C., Zambello, R., Masciarelli, M., Bulian, P., Agostini, C., Vinante, F., Zanotti, R. and Semenzato, G. (1989). Functional analysis of cytotoxic T-cells in patients with acute nonlymphoblastic leukemia in complete remission. Cancer, 64, 667-672.
6. Archimbaud, E., Bailly, M. and Dore, J. F. (1991). Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance. Br J Haematol, 77, 328-334.
7. Henney, C. S., Kuribayashi, K., Kern, D. E. and Gillis, S. (1981). Interleukin-2 augments natural killer activity. Nature, 291, 335-338.
8. Grimm, E. A., Mazumder, A., Zhang, H. Z. and Rosenberg, S. A. (1982). Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2-activated autologous human peripheral blood lymphocytes. J Exp Med, 160, 1823-1841.
9. Philips, J. H. and Lanier, L. L. (1986). Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T-lymphocytes to cytolysis. J Exp Med, 164, 814-825.
10. Tilden, A. B., Itoh, K. and Balch, C. M. (1987). Human lymphokine-activated killer (LAK) cells: Identification of two types of effector cells. J Immunol, 138, 1068-1073.
11. Landay, A. L., Zarcone, D., Grossi, C. E. and Bauer, K. (1987). Relationship between target cell cycle and susceptibility to natural killer lysis. Cancer Res, 47, 2767-2730.
12. Sellins, K. S. and Cohen, J. J. (1991). Cytotoxic T lymphocytes induce different types of DNA damage in target cells of different origin. J Immunol, 147, 795-803.
13. Cesano, A., Lista, P., Bellone, G., Geuna, M., Brizzi, M. F., Rossi, P. R., Pegoraro, L., Oberholzer, E. and Matera, L. (1992). Effect of human interleukin 3 on the susceptibility of fresh leukemia cells to interleukin-2-induced lymphokine activated killing activity. Leukemia, 6, 567-573.
14. Cesano, A., Clark, S. C. and Santoli, D. (1993). Cytokine modulation of the susceptibility of acute T-lymphoblastic leukemia cell lines to LAK activity. Leukemia, 7, 404-409.
15. McCoy, J. L., Herberman, R. B., Rosenberg, E. B., Donelly, F. C., Levine, P. H. and Alford, C. (1973). 51 Chromium release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue culture cells. Natl Cancer Inst Monogr, 37, 59-67.
16. Moore, M. A. S., Williams, N. and Metcalf, D. (1973). In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells. J Natl Cancer Inst, 50, 603-623.
17. Lotzova, E., Savary, C. A. and Herberman, R. B. (1987). Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors. Leuk Res, 11, 1059-1066.
18. Lista, P., Fierro, M. T., Liao, X. S., Bonferroni, M., Brizzi, M. F., Porcu, P., Pegoraro, L. and Foa, R. (1989). Lymphokine-activated killer (LAK) cells inhibit the clonogenic growth of human leukemic stem cells. Eur J Haematol, 42, 425-430.
19. Savary, C. A. and Lotzova, E. (1989). Natural killer cell-mediated inhibition of growth of myeloid and lymphoid clonogenic leukemias. Exp Hematol, 17, 183-187.
20. Perussia, B., Starr, S. and Abraham, S. (1983). Human natural killer cells analyzed by B73.1 monoclonal antibody blocking Fc receptor functions. I. Characterization of lymphocyte subset reactive with B73.1. J Immunol. 130, 2133-2141.
21. Pross, H. F., Baines, M. G., Rubin, P., Shragge, P. and Patterson, MS. (1981). Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol, 1, 51-64.
22. Welte, K., Platzer, E., Lu, L., Gabrilove, J. L., Levi, E., Mertelsmann, R. and Moore, M. A. S. (1985). Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA, 82, 1526-1530.
23. Archimbaud, E., Thomas, X., Vila, L., Sabido, O. and Campos, L. (1994). Expression of adhesion molecules in adult acute leukemia. In: N. G., Abraham, R. K. Shadduck, A. S. Levine and F. Takaku (eds): Molecular biology of haematopoiesis III, vol 3., pp 305-312. (Intercept, Andover.)
24. Hansson, M., Kiessling, R. and Andersson, B. (1981). Human fetal thymus and bone marrow contain target cells for natural killer cells. Eur J Immunol, 11, 8-14.
25. Hansson, M., Karre, K., Kiessling, R., Roder, J. C., Andersson, B. and Hatry, P. (1979). Natural killer cell targets in the mouse thymus: characteristics of the sensitive cell population. J Immunol, 123, 765-771.
26. Degliantoni, G., Perussia, B., Mongoni, L. and Trinchieri, G. (1985). Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity. J Exp Med, 161, 1152-1159.
27. Nitta, T., Yagita, H., Sato, K. and Okamura, K. (1989). Involvement of CD56 (NKH-1/Leu-19) as an adhesion molecule in natural killer-target cell interaction. J Exp Med, 170, 1757-1761.
28. Lanier, L. L., Testi, R., Bindl, J. and Philips, J. H. (1989). Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med, 169, 2233-2238.
29. Scheper, R. J., Dalton, W. S., Grogan, T. M., Schlosser, A., Bellamy, W. T., Taylor, C. W., Scuderi, P. and Spier, C. (1991). Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity. Int J Cancer, 48, 562-567.
30. Palucka, A. K., Porwit, A. and Reizenstein, P. (1991). Resistance of leukemic blasts to lymphokine activated killer (LAK)-mediated cytotoxicity is not related to their adhesion properties. Eur J Haematol, 47, 123-127.
31. Quilley-Mary, A., Caverec, L., Kermarrec, N., Marchiol-Foumigault, C., Gil, M. L., Conjeaud, H. and Fradelizi, D. (1991). Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets. Int J Cancer, 47, 473-479.
32. Archimbaud, E., Thomas, X., Campos, L., Magaud, J. P., Fiere, D. and Dore, J. P. (1991) Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells. Leukemia, 5, 967-971.
33. Triozzi, P. L., Eicher, D. M., Smoot, J. and Rinehart, J. J. (1992). Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: Role of intercellular adhesion molecule-1. Exp Hematol, 20, 1072-1076.
34. Arienti, F., Gambacorti-Passerini, C., Borin, L., Rivoltini, L., Orazi, A., Pogliani, E. M., Corneo, G. and Parmiani, G. (1992). Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules. Ann Oncol, 3, 155-162.
35. Anglaret, B., Thomas, X., Moullet, I., Bailly, M., Maritaz, O., Fiere, D. and Archimbaud, E. (1996). Differential adhesiveness on purified supports between blood and marrow leukemic cells having similar pattern of VLA adhesion molecule expression. Exp Hematol, 24, 1079.